...
首页> 外文期刊>Morbidity and Mortality Weekly Report: CDC Surveillance Summaries >Mumps Outbreaks at Four Universities a?? Indiana, 2016
【24h】

Mumps Outbreaks at Four Universities a?? Indiana, 2016

机译:流行性腮腺炎在四所大学爆发?印第安纳州,2016年

获取原文
   

获取外文期刊封面封底 >>

       

摘要

From February to April 2016, the Indiana State Department of Health (ISDH) confirmed mumps outbreaks at four universities (three public and one private). All universities were located within 65 miles of Indianapolis; however, epidemiologic links among outbreaks were limited. ISDH and local health departments investigated the outbreaks and initiated control measures at all universities. A protocol describing recommended testing for mumps, testing priorities during the outbreak, and a preauthorization process for submitting specimens to the ISDH Laboratory (ISDHL) was developed and disseminated to providers and public health partners (1). Outbreaks at each university were declared over after two incubation periods* elapsed without identified cases; the last outbreak ended September 10, 2016. Among the 281 confirmed and probable cases identified, 216 (76.9%) persons had documentation of presumptive evidence of immunity† (2). At some universities, documentation of receipt of 2 doses of measles, mumps, rubella vaccine (MMR), which is a criterion for evidence of immunity, was not available and required substantial personnel time to verify. Implementation of policies for excluding susceptible persons from classes and other group settings was also difficult. The laboratory testing protocol increased the percentage of specimens testing positive and improved case detection. Outbreak-specific laboratory testing guidance on specimen collection for mumps confirmation and standardized vaccination documentation in highly vaccinated settings could aid outbreak management. Evaluation of exclusion policies might also be necessary. In 2018, the Advisory Committee on Immunization Practices (ACIP) published a recommendation that persons previously vaccinated with 2 doses of MMR who are determined by public health authorities to be part of a group at increased risk for infection during a mumps outbreak receive a third dose of MMR (3).
机译:2016年2月至2016年4月,印第安纳州卫生部(ISDH)确认了四所大学(三所公立和一所私立)的腮腺炎暴发。所有大学都位于印第安纳波利斯65英里范围内;但是,暴发之间的流行病学联系是有限的。 ISDH和地方卫生部门对所有大学的疫情进行了调查,并采取了控制措施。制定了一项协议,描述了针对腮腺炎的推荐测试,暴发期间的测试重点以及将标本提交给ISDH实验室(ISDHL)的预授权过程,并已分发给提供者和公共卫生合作伙伴(1)。经过两个潜伏期*(未发现病例)后,宣布每所大学爆发疫情。上一次爆发于2016年9月10日结束。在确定的281例确诊和可能病例中,有216人(76.9%)有推定的免疫力证据†(2)。在一些大学中,尚无获得2剂麻疹,腮腺炎,风疹疫苗(MMR)疫苗的证据,这是免疫力的标准,需要大量人员进行验证。实施将易感人群排除在班级和其他团体环境之外的政策也很困难。实验室测试规程增加了阳性检测标本的百分比,并改善了病例检测。针对在高疫苗接种场所进行腮腺炎确认的标本采集的特定于暴发的实验室测试指南和标准化的疫苗接种文档可有助于暴发管理。还可能需要评估排除政策。 2018年,免疫实践咨询委员会(ACIP)发布了一项建议,即先前曾接受过2剂MMR疫苗接种的人被公共卫生当局确定为腮腺炎暴发期间感染风险增加的人群的一部分,应再接种第三剂MMR(3)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号